Cancer Treatment Reviews
Volume 26, Issue 2 , Pages 81-89, April 2000

Adjuvant interferon-alpha in malignant melanoma: current status☆

  • B.W. Hancock

      Affiliations

    • Weston Park Hospital, Sheffield
    • ,
  • S. Harris

      Affiliations

    • Weston Park Hospital, Sheffield
    • ,
  • K. Wheatley

      Affiliations

    • Clinical Trials Unit, University of Birmingham
    • ,
  • M. Gore

      Affiliations

    • Royal Marsden Hospital, London

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ The authors would like to acknowledge the support of The United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Melanoma Group.

PII: S0305-7372(99)90163-9

doi:10.1053/ctrv.1999.0163

Cancer Treatment Reviews
Volume 26, Issue 2 , Pages 81-89, April 2000

Article Tools